Skip to content

Development of Ayurveda fumigation instrument and treatment of non healing wound with fumigation

Development of dhoopan yantra with evaluation of srivasadi dhoopana karma in the management of dustavrana a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049612
Enrollment
20
Registered
2023-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L984- Non-pressure chronic ulcer of skin, not elsewhere classified

Interventions

None listed

Sponsors

Dr Ujjwal Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Either sex between 18 - 60 years of age Patients with the laxanas of Dustavrana.

Exclusion criteria

Exclusion criteria: Patients with known case of osteomyelitis, tuberculosis, malignant wounds, HbsAg, HIV I & II.

Design outcomes

Primary

MeasureTime frame
Srivasadi dhoopana karma is expected to be effective in dustavranaTimepoint: at baseline and 7th day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Santosh Y M

KAHER Shri BMK Ayurveda Mahavidhalaya Shahpur Belagavi

mysantosh.kaher@kleayurworld.edu.in8660800928

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026